Rongchang Biology (09995.HK) further purchased a total of 50 million yuan of Huatai Securities' wealth management products.

Zhijou Financial News App, Rongchang Biotech (09995.HK) announced that on May 20, 2026, the company further entered into (1) the Huatai Securities Wealth Management Product No.7 Agreement, in which the company agreed to purchase wealth management products from Huatai Securities for RMB 20 million of idle proprietary funds; and (2) the Huatai Securities Wealth Management Product No.8 Agreement, in which the company agreed to purchase wealth management products from Huatai Securities for RMB 30 million of idle proprietary funds.